HIV-AIDS – Pipeline Assessment and Market Forecasts to 2016 Now Available at ReportsandReports
The report identifies the key trends shaping and driving the global HIV/AIDS market. The report also provides insights on the prevalent competitive landscape and the companies expected to significantly alter the market landscape.
Dallas, TX, June 25, 2010 --(PR.com)-- ReportsandReports announce it will carry HIV-AIDS – Pipeline Assessment and Market Forecasts to 2016 Market Research Report in its Store.
Browse complete Report at: http://www.reportsandreports.com/market-reports/hiv-aids-pipeline-assessment-and-market-forecasts-to-2016/
GlobalData’s report, “HIV/AIDS – Pipeline Assessment and Market Forecasts to 2016” provides an essential source of information and analysis on the global HIV/AIDS market. The report identifies the key trends shaping and driving the global HIV/AIDS market. The report also provides insights on the prevalent competitive landscape and the companies expected to significantly alter the market landscape. Most importantly, the report provides valuable insights on the pipeline products within the global HIV/AIDS sector. GlobalData estimated the HIV/AIDS market was worth $12 billion in 2009. It is forecast to grow at a Compound Annual Growth Rate (CAGR) of 2% for the next seven years to reach $13.7 billion by 2016. The global Human Immunodeficiency Virus (HIV) infection market will continue to grow between 2009 and 2016 at a slower rate due to a series of patent expiries during this period.
The growth rate is likely to decline from 2012 onwards due to the impact of the patent expiry of key drugs. The market is characterized by a high unmet need of drugs which can cure the disease. Highly Active Antiretroviral Therapy (HAART) which requires patients to take different classes of drugs has however succeeded in achieving near zero levels of HIV in infected people. Increased uptake of HAART and increasing awareness (which leads to increased treatment seeking) will drive the market. The pipeline for HIV is strong and consists of more than 261 molecules currently in development for various disease segments.
Scope
The scope of the report includes:
* Annualized global HIV/AIDS market revenues data from 2001 to 2009, forecast for seven years to 2016.
* Pipeline analysis data providing a split across phases by mechanism of action, and the emerging trends. The key classes of mechanism of action include HIV vaccines, Nonnucleoside Reverse Transcriptase Inhibitors (NNRTIs), Protease Inhibitors (PIs), Multi-class Combination Products, Nucleoside Reverse Transcriptase Inhibitors (NRTIs), CCR5 receptor antagonists, HIV integrase inhibitors, Nucleoside analogues, Viral entry inhibitors, Maturation inhibitors and Fusion Inhibitors.
* Analysis of the current and future market competition in the global HIV/AIDS market. The key market players covered Boehring Ingelheim, Achillion Pharmaceuticals, GlaxoSmithKline, Incyte and Pharmasset, Shire Pharmaceuticals and Tibotec Virco
* Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.
* The key topics covered include a strategic competitor assessment, market characterization, unmet needs and implications for the future HIV/AIDS market.
Reasons to buy
The report will enhance your decision making capability in a more rapid and time sensitive manner. It will allow you to:
* Develop and design your in-licensing and out-licensing strategies through review of pipeline products and technologies and by identifying companies with the most robust pipeline.
* Develop business strategies by understanding the trends shaping and driving the global HIV/AIDS market.
* Drive revenues by understanding key trends, innovative products and technologies, market segments and companies likely to impact the global HIV/AIDS market in future.
* Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
* Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
* Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
* What’s the next big thing in the global HIV/AIDS market landscape? – Identify, understand and capitalize.
Browse complete Report at: http://www.reportsandreports.com/market-reports/hiv-aids-pipeline-assessment-and-market-forecasts-to-2016/
Browse all Pharmaceuticals Market Research Reports
Browse all GlobalData Market Research Reports
Browse all Latest Report
Related Reports:
Dyslipidemia – Pipeline Assessment and Market Forecasts to 2016
HIV/AIDS - Drug Pipeline Analysis and Market Forecasts to 2016
Global Endoscopes Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016
About Us:
Reports and Reports comprises an online library of 10,000 reports, in-depth market research studies of over 5000 micro markets, and 25 industry specific websites. Our client list boasts almost all well-known publishers of such reports across the globe. We as a third-party reseller of market research reports employ a number of marketing tools, such as press releases, email-marketing and effective search-engine optimization techniques to drive revenues for our clients. We also provide 24/7 online and offline support service to our customers.
Contact:
Ms. Sunita
7557 Rambler road,
Suite 727, Dallas, TX 75231
Tel: +1-888-989-8004
Website: http://www.reportsandreports.com/
Blog: http://reportsnreports.wordpress.com/
###
Browse complete Report at: http://www.reportsandreports.com/market-reports/hiv-aids-pipeline-assessment-and-market-forecasts-to-2016/
GlobalData’s report, “HIV/AIDS – Pipeline Assessment and Market Forecasts to 2016” provides an essential source of information and analysis on the global HIV/AIDS market. The report identifies the key trends shaping and driving the global HIV/AIDS market. The report also provides insights on the prevalent competitive landscape and the companies expected to significantly alter the market landscape. Most importantly, the report provides valuable insights on the pipeline products within the global HIV/AIDS sector. GlobalData estimated the HIV/AIDS market was worth $12 billion in 2009. It is forecast to grow at a Compound Annual Growth Rate (CAGR) of 2% for the next seven years to reach $13.7 billion by 2016. The global Human Immunodeficiency Virus (HIV) infection market will continue to grow between 2009 and 2016 at a slower rate due to a series of patent expiries during this period.
The growth rate is likely to decline from 2012 onwards due to the impact of the patent expiry of key drugs. The market is characterized by a high unmet need of drugs which can cure the disease. Highly Active Antiretroviral Therapy (HAART) which requires patients to take different classes of drugs has however succeeded in achieving near zero levels of HIV in infected people. Increased uptake of HAART and increasing awareness (which leads to increased treatment seeking) will drive the market. The pipeline for HIV is strong and consists of more than 261 molecules currently in development for various disease segments.
Scope
The scope of the report includes:
* Annualized global HIV/AIDS market revenues data from 2001 to 2009, forecast for seven years to 2016.
* Pipeline analysis data providing a split across phases by mechanism of action, and the emerging trends. The key classes of mechanism of action include HIV vaccines, Nonnucleoside Reverse Transcriptase Inhibitors (NNRTIs), Protease Inhibitors (PIs), Multi-class Combination Products, Nucleoside Reverse Transcriptase Inhibitors (NRTIs), CCR5 receptor antagonists, HIV integrase inhibitors, Nucleoside analogues, Viral entry inhibitors, Maturation inhibitors and Fusion Inhibitors.
* Analysis of the current and future market competition in the global HIV/AIDS market. The key market players covered Boehring Ingelheim, Achillion Pharmaceuticals, GlaxoSmithKline, Incyte and Pharmasset, Shire Pharmaceuticals and Tibotec Virco
* Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.
* The key topics covered include a strategic competitor assessment, market characterization, unmet needs and implications for the future HIV/AIDS market.
Reasons to buy
The report will enhance your decision making capability in a more rapid and time sensitive manner. It will allow you to:
* Develop and design your in-licensing and out-licensing strategies through review of pipeline products and technologies and by identifying companies with the most robust pipeline.
* Develop business strategies by understanding the trends shaping and driving the global HIV/AIDS market.
* Drive revenues by understanding key trends, innovative products and technologies, market segments and companies likely to impact the global HIV/AIDS market in future.
* Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
* Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
* Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
* What’s the next big thing in the global HIV/AIDS market landscape? – Identify, understand and capitalize.
Browse complete Report at: http://www.reportsandreports.com/market-reports/hiv-aids-pipeline-assessment-and-market-forecasts-to-2016/
Browse all Pharmaceuticals Market Research Reports
Browse all GlobalData Market Research Reports
Browse all Latest Report
Related Reports:
Dyslipidemia – Pipeline Assessment and Market Forecasts to 2016
HIV/AIDS - Drug Pipeline Analysis and Market Forecasts to 2016
Global Endoscopes Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016
About Us:
Reports and Reports comprises an online library of 10,000 reports, in-depth market research studies of over 5000 micro markets, and 25 industry specific websites. Our client list boasts almost all well-known publishers of such reports across the globe. We as a third-party reseller of market research reports employ a number of marketing tools, such as press releases, email-marketing and effective search-engine optimization techniques to drive revenues for our clients. We also provide 24/7 online and offline support service to our customers.
Contact:
Ms. Sunita
7557 Rambler road,
Suite 727, Dallas, TX 75231
Tel: +1-888-989-8004
Website: http://www.reportsandreports.com/
Blog: http://reportsnreports.wordpress.com/
###
Contact
ReportsandReports
Gourav Mathankar
+1-888-989-8004
http://www.reportsandreports.com/
Ms. Sunita
7557 Rambler road,
Suite 727, Dallas, TX 75231
Gourav Mathankar
+1-888-989-8004
http://www.reportsandreports.com/
Ms. Sunita
7557 Rambler road,
Suite 727, Dallas, TX 75231
Contact
Categories